$RNN Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Ocuphire Pharma, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Ocuphire Pharma, Inc.. Get notifications about new insider transactions in Ocuphire Pharma, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 11 2014 | RNN | REXAHN PHARMACEUTI ... | Brandt Peter C. | Director | Option Exercise | A | 0.90 | 60,000 | 54,000 | 60,000 | |
Jun 11 2014 | RNN | REXAHN PHARMACEUTI ... | CARTHY MARK | Director | Option Exercise | A | 0.90 | 60,000 | 54,000 | 60,000 | |
Jun 11 2014 | RNN | REXAHN PHARMACEUTI ... | Beever Charles | Director | Option Exercise | A | 0.90 | 60,000 | 54,000 | 60,000 | |
Jun 11 2014 | RNN | REXAHN PHARMACEUTI ... | Cheong Kwang Soo | Director | Option Exercise | A | 0.90 | 60,000 | 54,000 | 60,000 | |
Apr 16 2014 | RNN | REXAHN PHARMACEUTI ... | McIntosh David M | Director | Option Exercise | M | 0.80 | 125,000 | 100,000 | 0 | |
Apr 16 2014 | RNN | REXAHN PHARMACEUTI ... | McIntosh David M | Director | Payment of Exercise | F | 1.01 | 99,010 | 100,000 | 25,990 | 125 K to 26 K (-79.21 %) |
Apr 16 2014 | RNN | REXAHN PHARMACEUTI ... | McIntosh David M | Director | Buy | M | 0.80 | 125,000 | 100,000 | 125,000 | 0 to 125 K |
Mar 03 2014 | RNN | REXAHN PHARMACEUTI ... | CARTHY MARK | Director | Option Exercise | A | 1.35 | 20,000 | 27,000 | 20,000 | |
Jan 14 2014 | RNN | REXAHN PHARMACEUTI ... | Jeong Tae Heum | Chief Financial Off ... | Option Exercise | A | 1.14 | 175,000 | 199,500 | 175,000 | |
Jan 14 2014 | RNN | REXAHN PHARMACEUTI ... | Ahn Chang Ho | Director | Option Exercise | A | 1.14 | 125,000 | 142,500 | 125,000 | |
Jan 14 2014 | RNN | REXAHN PHARMACEUTI ... | Soni Rakesh | President and COO | Option Exercise | A | 1.14 | 85,000 | 96,900 | 85,000 | |
Jan 14 2014 | RNN | REXAHN PHARMACEUTI ... | Suzdak Peter David | Chief Executive Off ... | Option Exercise | A | 1.14 | 350,000 | 399,000 | 350,000 | |
Sep 11 2013 | RNN | REXAHN PHARMACEUTI ... | Jeong Tae Heum | Chief Financial Off ... | Option Exercise | M | 0.24 | 150,000 | 36,000 | 0 | |
Sep 11 2013 | RNN | REXAHN PHARMACEUTI ... | Jeong Tae Heum | Chief Financial Off ... | Sell | S | 0.46 | 71,139 | 32,475 | 505,000 | 576.1 K to 505 K (-12.35 %) |
Sep 11 2013 | RNN | REXAHN PHARMACEUTI ... | Jeong Tae Heum | Chief Financial Off ... | Payment of Exercise | F | 0.46 | 78,861 | 36,000 | 576,139 | 655 K to 576.1 K (-12.04 %) |
Sep 11 2013 | RNN | REXAHN PHARMACEUTI ... | Jeong Tae Heum | Chief Financial Off ... | Buy | M | 0.24 | 150,000 | 36,000 | 655,000 | 505 K to 655 K (+29.70 %) |
Jun 13 2013 | RNN | REXAHN PHARMACEUTI ... | Beever Charles | Director | Option Exercise | A | 0.50 | 60,000 | 30,000 | 60,000 | |
Jun 13 2013 | RNN | REXAHN PHARMACEUTI ... | McIntosh David M | Director | Option Exercise | A | 0.50 | 60,000 | 30,000 | 60,000 | |
Jun 13 2013 | RNN | REXAHN PHARMACEUTI ... | Brandt Peter C. | Director | Option Exercise | A | 0.50 | 60,000 | 30,000 | 60,000 | |
Jun 13 2013 | RNN | REXAHN PHARMACEUTI ... | Cheong Kwang Soo | Director | Option Exercise | A | 0.50 | 60,000 | 30,000 | 60,000 | |
Jun 13 2013 | RNN | REXAHN PHARMACEUTI ... | Hwang Si Moon | Director | Option Exercise | A | 0.50 | 60,000 | 30,000 | 60,000 | |
Mar 05 2013 | RNN | REXAHN PHARMACEUTI ... | Soni Rakesh | President and COO | Option Exercise | A | 0.31 | 50,000 | 15,500 | 50,000 | |
Mar 05 2013 | RNN | REXAHN PHARMACEUTI ... | Ahn Chang Ho | Director | Option Exercise | A | 0.31 | 250,000 | 77,500 | 250,000 | |
Mar 05 2013 | RNN | REXAHN PHARMACEUTI ... | Jeong Tae Heum | Chief Financial Off ... | Option Exercise | A | 0.31 | 250,000 | 77,500 | 250,000 | |
Feb 06 2013 | RNN | REXAHN PHARMACEUTI ... | Suzdak Peter David | Chief Executive Off ... | Option Exercise | A | 0.37 | 1,200,000 | 444,000 | 1,200,000 | |
Jun 20 2012 | RNN | REXAHN PHARMACEUTI ... | Kivel Richard | Director | Option Exercise | A | 0.38 | 20,000 | 7,600 | 20,000 | |
Jun 26 2012 | RNN | REXAHN PHARMACEUTI ... | Hwang Si Moon | Director | Option Exercise | A | 0.38 | 20,000 | 7,600 | 20,000 | |
Jun 20 2012 | RNN | REXAHN PHARMACEUTI ... | McIntosh David M | Director | Option Exercise | A | 0.38 | 20,000 | 7,600 | 20,000 | |
Jun 20 2012 | RNN | REXAHN PHARMACEUTI ... | Brandt Peter C. | Director | Option Exercise | A | 0.38 | 20,000 | 7,600 | 20,000 | |
Jun 20 2012 | RNN | REXAHN PHARMACEUTI ... | Cheong Kwang Soo | Director | Option Exercise | A | 0.38 | 20,000 | 7,600 | 20,000 | |
Jun 20 2012 | RNN | REXAHN PHARMACEUTI ... | Beever Charles | Director | Option Exercise | A | 0.38 | 20,000 | 7,600 | 20,000 | |
Oct 21 2011 | RNN | REXAHN PHARMACEUTI ... | Kivel Richard | Director | Buy | P | 1.04 | 2,500 | 2,600 | 2,500 | 0 to 2.5 K |
Sep 12 2011 | RNN | REXAHN PHARMACEUTI ... | Brandt Peter C. | Director | Buy | P | 1.23 | 5,000 | 6,150 | 150,000 | 145 K to 150 K (+3.45 %) |
Sep 12 2011 | RNN | REXAHN PHARMACEUTI ... | Brandt Peter C. | Director | Buy | P | 1.22 | 13,300 | 16,213 | 145,000 | 131.7 K to 145 K (+10.10 %) |
Sep 12 2011 | RNN | REXAHN PHARMACEUTI ... | Brandt Peter C. | Director | Buy | P | 1.22 | 55,100 | 67,222 | 131,700 | 76.6 K to 131.7 K (+71.93 %) |
Sep 12 2011 | RNN | REXAHN PHARMACEUTI ... | Brandt Peter C. | Director | Buy | P | 1.21 | 6,600 | 7,986 | 76,600 | 70 K to 76.6 K (+9.43 %) |
Sep 12 2011 | RNN | REXAHN PHARMACEUTI ... | Brandt Peter C. | Director | Buy | P | 1.08 | 15,000 | 16,185 | 70,000 | 55 K to 70 K (+27.27 %) |
Sep 12 2011 | RNN | REXAHN PHARMACEUTI ... | Brandt Peter C. | Director | Buy | P | 1.10 | 2,500 | 2,748 | 55,000 | 52.5 K to 55 K (+4.76 %) |
Sep 12 2011 | RNN | REXAHN PHARMACEUTI ... | Brandt Peter C. | Director | Buy | P | 1.09 | 5,912 | 6,444 | 52,500 | 46.6 K to 52.5 K (+12.69 %) |
Sep 12 2011 | RNN | REXAHN PHARMACEUTI ... | Brandt Peter C. | Director | Buy | P | 1.10 | 13,800 | 15,180 | 46,588 | 32.8 K to 46.6 K (+42.09 %) |
Sep 12 2011 | RNN | REXAHN PHARMACEUTI ... | Brandt Peter C. | Director | Buy | P | 1.12 | 7,200 | 8,064 | 32,788 | 25.6 K to 32.8 K (+28.14 %) |
Sep 12 2011 | RNN | REXAHN PHARMACEUTI ... | Brandt Peter C. | Director | Buy | P | 1.13 | 588 | 664 | 25,588 | 25 K to 25.6 K (+2.35 %) |
Sep 08 2011 | RNN | REXAHN PHARMACEUTI ... | Brandt Peter C. | Director | Buy | P | 1.04 | 5,000 | 5,200 | 25,000 | 20 K to 25 K (+25.00 %) |
Sep 08 2011 | RNN | REXAHN PHARMACEUTI ... | Brandt Peter C. | Director | Buy | P | 0.95 | 300 | 284 | 20,000 | 19.7 K to 20 K (+1.52 %) |
Sep 08 2011 | RNN | REXAHN PHARMACEUTI ... | Brandt Peter C. | Director | Buy | P | 0.95 | 4,500 | 4,253 | 19,700 | 15.2 K to 19.7 K (+29.61 %) |
Sep 08 2011 | RNN | REXAHN PHARMACEUTI ... | Brandt Peter C. | Director | Buy | P | 0.94 | 300 | 283 | 15,200 | 14.9 K to 15.2 K (+2.01 %) |
Sep 08 2011 | RNN | REXAHN PHARMACEUTI ... | Brandt Peter C. | Director | Buy | P | 0.95 | 3,900 | 3,686 | 14,900 | 11 K to 14.9 K (+35.45 %) |
Sep 08 2011 | RNN | REXAHN PHARMACEUTI ... | Brandt Peter C. | Director | Buy | P | 0.95 | 5,300 | 5,019 | 11,000 | 5.7 K to 11 K (+92.98 %) |
Sep 08 2011 | RNN | REXAHN PHARMACEUTI ... | Brandt Peter C. | Director | Buy | P | 0.95 | 2,450 | 2,318 | 5,700 | 3.3 K to 5.7 K (+75.38 %) |
Sep 08 2011 | RNN | REXAHN PHARMACEUTI ... | Brandt Peter C. | Director | Buy | P | 0.95 | 3,250 | 3,081 | 3,250 | 0 to 3.3 K |
Jun 08 2011 | RNN | REXAHN PHARMACEUTI ... | Beever Charles | Director | Option Exercise | A | 1.25 | 20,000 | 25,000 | 20,000 | |
Jun 08 2011 | RNN | REXAHN PHARMACEUTI ... | Brandt Peter C. | Director | Option Exercise | A | 1.25 | 20,000 | 25,000 | 20,000 | |
Jun 08 2011 | RNN | REXAHN PHARMACEUTI ... | McIntosh David M | Director | Option Exercise | A | 1.25 | 20,000 | 25,000 | 20,000 | |
Jun 08 2011 | RNN | REXAHN PHARMACEUTI ... | Cheong Kwang Soo | Director | Option Exercise | A | 1.25 | 20,000 | 25,000 | 20,000 | |
May 20 2011 | RNN | REXAHN PHARMACEUTI ... | Ahn Chang Ho | Chairman & CEO | Buy | P | 1.31 | 1,008,078 | 1,320,582 | 11,338,924 | 10.3 M to 11.3 M (+9.76 %) |
Jun 08 2011 | RNN | REXAHN PHARMACEUTI ... | Kivel Richard | Director | Option Exercise | A | 1.25 | 20,000 | 25,000 | 20,000 | |
Apr 05 2011 | RNN | REXAHN PHARMACEUTI ... | Ahn Chang Ho | Chairman & CEO | Buy | P | 1.22 | 320,846 | 391,432 | 10,330,846 | 10 M to 10.3 M (+3.21 %) |
Dec 17 2010 | RNN | REXAHN PHARMACEUTI ... | Ahn Chang Ho | Chairman & CEO | Gift | G | 0.00 | 210,000 | 0 | 10,010,000 | 10.2 M to 10 M (-2.05 %) |
Dec 17 2010 | RNN | REXAHN PHARMACEUTI ... | Ahn Chang Ho | Chairman & CEO | Gift | G | 0.00 | 300,000 | 0 | 10,220,000 | 10.5 M to 10.2 M (-2.85 %) |
Oct 25 2010 | RNN | REXAHN PHARMACEUTI ... | Brandt Peter C. | Director | Option Exercise | A | 1.19 | 20,000 | 23,800 | 20,000 | |
Oct 25 2010 | RNN | REXAHN PHARMACEUTI ... | Kivel Richard | Director | Option Exercise | A | 1.19 | 20,000 | 23,800 | 20,000 | |
Oct 25 2010 | RNN | REXAHN PHARMACEUTI ... | McIntosh David M | Director | Option Exercise | A | 1.17 | 20,000 | 23,400 | 20,000 | |
Oct 25 2010 | RNN | REXAHN PHARMACEUTI ... | Cheong Kwang Soo | Director | Option Exercise | A | 1.17 | 20,000 | 23,400 | 20,000 | |
Oct 25 2010 | RNN | REXAHN PHARMACEUTI ... | Beever Charles | Director | Option Exercise | A | 1.17 | 20,000 | 23,400 | 20,000 | |
Aug 05 2009 | RNN | REXAHN PHARMACEUTI ... | McIntosh David M | Director | Buy | P | 0.80 | 2,800 | 2,240 | 2,800 | 0 to 2.8 K |
Aug 05 2009 | RNN | REXAHN PHARMACEUTI ... | McIntosh David M | Director | Buy | P | 0.80 | 2,800 | 2,240 | 2,800 | 0 to 2.8 K |
Jun 02 2009 | RNN | REXAHN PHARMACEUTI ... | McIntosh David M | Director | Option Exercise | A | 1.28 | 20,000 | 25,600 | 20,000 | |
Jun 02 2009 | RNN | REXAHN PHARMACEUTI ... | Cheong Kwang Soo | Director | Option Exercise | A | 1.28 | 20,000 | 25,600 | 20,000 | |
Jun 02 2009 | RNN | REXAHN PHARMACEUTI ... | Hoffman Freddie Ann | Director | Option Exercise | A | 1.28 | 20,000 | 25,600 | 20,000 | |
Jun 02 2009 | RNN | REXAHN PHARMACEUTI ... | Beever Charles | Director | Option Exercise | A | 1.28 | 20,000 | 25,600 | 20,000 | |
Jun 02 2009 | RNN | REXAHN PHARMACEUTI ... | Kang Y Michele | Director | Option Exercise | A | 1.28 | 20,000 | 25,600 | 20,000 | |
May 04 2009 | RNN | REXAHN PHARMACEUTI ... | Ahn Chang Ho | Chairman & CEO | Buy | P | 0.68 | 260,000 | 176,800 | 10,520,000 | 10.3 M to 10.5 M (+2.53 %) |
May 04 2009 | RNN | REXAHN PHARMACEUTI ... | Ahn Chang Ho | Chairman & CEO | Sell | S | 0.68 | 2,600,000 | 1,768,000 | 10,260,000 | 12.9 M to 10.3 M (-20.22 %) |
May 04 2009 | RNN | REXAHN PHARMACEUTI ... | Ahn Chang Ho | Chairman & CEO | Gift | G | 0.00 | 400,000 | 0 | 12,860,000 | 13.3 M to 12.9 M (-3.02 %) |
Aug 27 2008 | RNN | REXAHN PHARMACEUTI ... | Hoffman Freddie Ann | Director | Option Exercise | A | 3.24 | 20,000 | 64,800 | 20,000 | |
Aug 27 2008 | RNN | REXAHN PHARMACEUTI ... | Kang Y Michele | Director | Option Exercise | A | 1.47 | 150,000 | 220,500 | 150,000 | |
Aug 27 2008 | RNN | REXAHN PHARMACEUTI ... | Kang Y Michele | Director | Option Exercise | A | 3.24 | 20,000 | 64,800 | 20,000 | |
Aug 27 2008 | RNN | REXAHN PHARMACEUTI ... | Beever Charles | Director | Option Exercise | A | 3.24 | 20,000 | 64,800 | 20,000 | |
Aug 27 2008 | RNN | REXAHN PHARMACEUTI ... | Cheong Kwang Soo | Director | Option Exercise | A | 3.24 | 20,000 | 64,800 | 20,000 | |
Aug 27 2008 | RNN | REXAHN PHARMACEUTI ... | McIntosh David M | Director | Option Exercise | A | 3.24 | 20,000 | 64,800 | 20,000 | |
Apr 25 2008 | RNN | REXAHN PHARMACEUTI ... | Kang Y Michele | Director | Buy | P | 2.35 | 1,500 | 3,525 | 10,000 | 8.5 K to 10 K (+17.65 %) |
Apr 25 2008 | RNN | REXAHN PHARMACEUTI ... | Kang Y Michele | Director | Buy | P | 2.35 | 500 | 1,175 | 8,500 | 8 K to 8.5 K (+6.25 %) |
Apr 25 2008 | RNN | REXAHN PHARMACEUTI ... | Kang Y Michele | Director | Buy | P | 2.25 | 500 | 1,125 | 8,000 | 7.5 K to 8 K (+6.67 %) |
Apr 25 2008 | RNN | REXAHN PHARMACEUTI ... | Kang Y Michele | Director | Buy | P | 2.30 | 2,500 | 5,750 | 7,500 | 5 K to 7.5 K (+50.00 %) |
Apr 25 2008 | RNN | REXAHN PHARMACEUTI ... | Kang Y Michele | Director | Buy | P | 2.30 | 1,000 | 2,300 | 5,000 | 4 K to 5 K (+25.00 %) |
Apr 25 2008 | RNN | REXAHN PHARMACEUTI ... | Kang Y Michele | Director | Buy | P | 2.35 | 1,000 | 2,350 | 4,000 | 3 K to 4 K (+33.33 %) |
Apr 25 2008 | RNN | REXAHN PHARMACEUTI ... | Kang Y Michele | Director | Buy | P | 2.35 | 1,000 | 2,350 | 3,000 | 2 K to 3 K (+50.00 %) |
Apr 25 2008 | RNN | REXAHN PHARMACEUTI ... | Kang Y Michele | Director | Buy | P | 2.35 | 1,000 | 2,350 | 2,000 | 1,000 to 2 K (+100.00 %) |
Apr 25 2008 | RNN | REXAHN PHARMACEUTI ... | Kang Y Michele | Director | Buy | P | 2.35 | 1,000 | 2,350 | 1,000 | 0 to 1,000 |
May 06 2008 | RNN | REXAHN PHARMACEUTI ... | Cheong Kwang Soo | Director | Buy | P | 2.25 | 3,000 | 6,750 | 3,000 | 0 to 3 K |
Apr 16 2008 | RNN | REXAHN PHARMACEUTI ... | Hoffman Freddie Ann | Director | Buy | P | 2.20 | 1,000 | 2,200 | 1,000 | 0 to 1,000 |
Apr 23 2008 | RNN | REXAHN PHARMACEUTI ... | Jeong Tae Heum | CFO | Buy | P | 1.99 | 1,300 | 2,587 | 505,000 | 503.7 K to 505 K (+0.26 %) |
Apr 23 2008 | RNN | REXAHN PHARMACEUTI ... | Jeong Tae Heum | CFO | Buy | P | 2.35 | 3,700 | 8,695 | 503,700 | 500 K to 503.7 K (+0.74 %) |
Apr 15 2008 | RNN | REXAHN PHARMACEUTI ... | Ahn Chang Ho | Chairman & CEO | Buy | P | 2.20 | 500 | 1,100 | 14,010,000 | 14 M to 14 M (0.00 %) |
Apr 15 2008 | RNN | REXAHN PHARMACEUTI ... | Ahn Chang Ho | Chairman & CEO | Buy | P | 2.39 | 4,000 | 9,560 | 14,009,500 | 14 M to 14 M (+0.03 %) |
Apr 15 2008 | RNN | REXAHN PHARMACEUTI ... | Ahn Chang Ho | Chairman & CEO | Buy | P | 2.40 | 1,000 | 2,395 | 14,005,500 | 14 M to 14 M (+0.01 %) |
Apr 15 2008 | RNN | REXAHN PHARMACEUTI ... | Ahn Chang Ho | Chairman & CEO | Buy | P | 2.40 | 2,000 | 4,800 | 14,004,500 | 14 M to 14 M (+0.01 %) |
Apr 15 2008 | RNN | REXAHN PHARMACEUTI ... | Ahn Chang Ho | Chairman & CEO | Buy | P | 2.45 | 2,500 | 6,125 | 14,002,500 | 14 M to 14 M (+0.02 %) |
Apr 10 2008 | RNN | REXAHN PHARMACEUTI ... | Beever Charles | Director | Buy | P | 2.25 | 500 | 1,125 | 10,000 | 9.5 K to 10 K (+5.26 %) |
Apr 10 2008 | RNN | REXAHN PHARMACEUTI ... | Beever Charles | Director | Buy | P | 2.30 | 500 | 1,150 | 9,500 | 9 K to 9.5 K (+5.56 %) |
Apr 10 2008 | RNN | REXAHN PHARMACEUTI ... | Beever Charles | Director | Buy | P | 2.35 | 500 | 1,175 | 9,000 | 8.5 K to 9 K (+5.88 %) |
Apr 10 2008 | RNN | REXAHN PHARMACEUTI ... | Beever Charles | Director | Buy | P | 2.40 | 1,178 | 2,827 | 8,500 | 7.3 K to 8.5 K (+16.09 %) |
Apr 10 2008 | RNN | REXAHN PHARMACEUTI ... | Beever Charles | Director | Buy | P | 2.49 | 500 | 1,245 | 7,322 | 6.8 K to 7.3 K (+7.33 %) |
Apr 10 2008 | RNN | REXAHN PHARMACEUTI ... | Beever Charles | Director | Buy | P | 2.50 | 1,960 | 4,890 | 6,822 | 4.9 K to 6.8 K (+40.31 %) |
Apr 10 2008 | RNN | REXAHN PHARMACEUTI ... | Beever Charles | Director | Buy | P | 2.50 | 500 | 1,248 | 4,862 | 4.4 K to 4.9 K (+11.46 %) |
Apr 10 2008 | RNN | REXAHN PHARMACEUTI ... | Beever Charles | Director | Buy | P | 2.50 | 3,362 | 8,405 | 4,362 | 1,000 to 4.4 K (+336.20 %) |
Apr 10 2008 | RNN | REXAHN PHARMACEUTI ... | Beever Charles | Director | Buy | P | 2.50 | 1,000 | 2,500 | 1,000 | 0 to 1,000 |
Dec 26 2007 | RNN | REXAHN PHARMACEUTI ... | Rexgene Biotech Co., Ltd. | 10% Owner | Option Exercise | A | 1.80 | 142,857 | 257,143 | 142,857 | |
Dec 26 2007 | RNN | REXAHN PHARMACEUTI ... | Rexgene Biotech Co., Ltd. | 10% Owner | Grant | A | 1.40 | 714,286 | 1,000,000 | 5,505,956 | 4.8 M to 5.5 M (+14.91 %) |
Jun 13 2007 | RNN | REXAHN PHARMACEUTI ... | Kang Y Michele | Director | Option Exercise | A | 1.40 | 20,000 | 28,000 | 20,000 | |
Jun 13 2007 | RNN | REXAHN PHARMACEUTI ... | McIntosh David M | Director | Option Exercise | A | 1.40 | 20,000 | 28,000 | 20,000 | |
Jun 13 2007 | RNN | REXAHN PHARMACEUTI ... | Cheong Kwang Soo | Director | Option Exercise | A | 1.40 | 20,000 | 28,000 | 20,000 | |
Jun 13 2007 | RNN | REXAHN PHARMACEUTI ... | Beever Charles | Director | Option Exercise | A | 1.40 | 20,000 | 28,000 | 20,000 | |
Jun 13 2007 | RNN | REXAHN PHARMACEUTI ... | Hoffman Freddie Ann | Director | Option Exercise | A | 1.40 | 20,000 | 28,000 | 20,000 | |
Jan 08 2007 | RNN | REXAHN PHARMACEUTI ... | Park Young Soon | Director | Gift | G | 0.00 | 200,000 | 0 | 2,040,500 | 2.2 M to 2 M (-8.93 %) |
Jan 08 2007 | RNN | REXAHN PHARMACEUTI ... | Park Young Soon | Director | Gift | G | 0.00 | 500,000 | 0 | 500,000 | 0 to 500 K |
Jan 08 2007 | RNN | REXAHN PHARMACEUTI ... | Park Young Soon | Director | Gift | G | 0.00 | 500,000 | 0 | 2,240,500 | 2.7 M to 2.2 M (-18.24 %) |
Jan 08 2007 | RNN | REXAHN PHARMACEUTI ... | Park Young Soon | Director | Sell | S | 0.31 | 384,500 | 119,195 | 2,740,500 | 3.1 M to 2.7 M (-12.30 %) |
Jan 08 2007 | RNN | REXAHN PHARMACEUTI ... | Park Young Soon | Director | Buy | J | 0.00 | 166,000 | 0 | 3,125,000 | 3 M to 3.1 M (+5.61 %) |
May 03 2006 | RNN | REXAHN PHARMACEUTI ... | HOLADAY JOHN W DR | Director | Option Exercise | A | 3.00 | 20,000 | 60,000 | 20,000 | |
May 03 2006 | RNN | REXAHN PHARMACEUTI ... | HOLADAY JOHN W DR | Director | Option Exercise | D | 3.00 | 20,000 | 60,000 | 0 | |
May 03 2006 | RNN | REXAHN PHARMACEUTI ... | HOLADAY JOHN W DR | Director | Option Exercise | A | 0.80 | 125,000 | 100,000 | 125,000 | |
May 03 2006 | RNN | REXAHN PHARMACEUTI ... | HOLADAY JOHN W DR | Director | Option Exercise | D | 0.80 | 125,000 | 100,000 | 0 | |
May 03 2006 | RNN | REXAHN PHARMACEUTI ... | HOLADAY JOHN W DR | Director | Option Exercise | A | 0.80 | 70,000 | 56,000 | 70,000 | |
May 03 2006 | RNN | REXAHN PHARMACEUTI ... | HOLADAY JOHN W DR | Director | Option Exercise | D | 0.80 | 70,000 | 56,000 | 0 | |
May 03 2006 | RNN | REXAHN PHARMACEUTI ... | HOLADAY JOHN W DR | Director | Option Exercise | A | 3.00 | 20,000 | 60,000 | 20,000 | |
May 03 2006 | RNN | REXAHN PHARMACEUTI ... | HOLADAY JOHN W DR | Director | Option Exercise | A | 0.80 | 125,000 | 100,000 | 125,000 | |
May 03 2006 | RNN | REXAHN PHARMACEUTI ... | HOLADAY JOHN W DR | Director | Option Exercise | D | 0.24 | 125,000 | 30,000 | 0 | |
May 03 2006 | RNN | REXAHN PHARMACEUTI ... | HOLADAY JOHN W DR | Director | Option Exercise | A | 0.80 | 70,000 | 56,000 | 70,000 | |
May 03 2006 | RNN | REXAHN PHARMACEUTI ... | HOLADAY JOHN W DR | Director | Option Exercise | D | 0.24 | 70,000 | 16,800 | 30,000 | |
May 03 2006 | RNN | REXAHN PHARMACEUTI ... | McIntosh David M | Director | Option Exercise | A | 1.20 | 20,000 | 24,000 | 20,000 | |
May 03 2006 | RNN | REXAHN PHARMACEUTI ... | McIntosh David M | Director | Option Exercise | A | 3.00 | 20,000 | 60,000 | 20,000 | |
May 03 2006 | RNN | REXAHN PHARMACEUTI ... | McIntosh David M | Director | Option Exercise | A | 0.80 | 125,000 | 100,000 | 125,000 | |
May 03 2006 | RNN | REXAHN PHARMACEUTI ... | McIntosh David M | Director | Option Exercise | D | 0.24 | 125,000 | 30,000 | 0 | |
May 03 2006 | RNN | REXAHN PHARMACEUTI ... | Jeong Tae Heum | CFO and Secretary | Option Exercise | A | 0.80 | 500,000 | 400,000 | 500,000 | |
May 03 2006 | RNN | REXAHN PHARMACEUTI ... | Jeong Tae Heum | CFO and Secretary | Option Exercise | D | 0.24 | 500,000 | 120,000 | 0 | |
May 03 2006 | RNN | REXAHN PHARMACEUTI ... | Jeong Tae Heum | CFO and Secretary | Option Exercise | A | 0.80 | 100,000 | 80,000 | 100,000 | |
May 03 2006 | RNN | REXAHN PHARMACEUTI ... | Jeong Tae Heum | CFO and Secretary | Option Exercise | D | 0.24 | 100,000 | 24,000 | 150,000 | |
May 03 2006 | RNN | REXAHN PHARMACEUTI ... | Steinfels George F | Chief Business Offi ... | Option Exercise | A | 0.80 | 500,000 | 400,000 | 500,000 | |
May 03 2006 | RNN | REXAHN PHARMACEUTI ... | Steinfels George F | Chief Business Offi ... | Option Exercise | D | 0.24 | 500,000 | 120,000 | 0 | |
May 03 2006 | RNN | REXAHN PHARMACEUTI ... | Steinfels George F | Chief Business Offi ... | Option Exercise | A | 0.80 | 250,000 | 200,000 | 250,000 | |
May 03 2006 | RNN | REXAHN PHARMACEUTI ... | Steinfels George F | Chief Business Offi ... | Option Exercise | D | 0.24 | 250,000 | 60,000 | 0 | |
May 03 2006 | RNN | REXAHN PHARMACEUTI ... | Ahn Chang Ho | Director | Option Exercise | A | 0.80 | 500,000 | 400,000 | 500,000 | |
May 03 2006 | RNN | REXAHN PHARMACEUTI ... | Ahn Chang Ho | Director | Option Exercise | D | 0.24 | 500,000 | 120,000 | 0 | |
May 03 2006 | RNN | REXAHN PHARMACEUTI ... | Ahn Chang Ho | Director | Option Exercise | A | 0.80 | 1,000,000 | 800,000 | 1,000,000 | |
May 03 2006 | RNN | REXAHN PHARMACEUTI ... | Ahn Chang Ho | Director | Option Exercise | D | 0.24 | 1,000,000 | 240,000 | 0 | |
May 03 2006 | RNN | REXAHN PHARMACEUTI ... | Park Young Soon | Director | Option Exercise | A | 1.20 | 20,000 | 24,000 | 20,000 | |
May 03 2006 | RNN | REXAHN PHARMACEUTI ... | Park Young Soon | Director | Option Exercise | A | 3.00 | 220,000 | 660,000 | 220,000 | |
May 03 2006 | RNN | REXAHN PHARMACEUTI ... | Ahn Inok | Director | Option Exercise | A | 0.80 | 1,000,000 | 800,000 | 1,000,000 | |
May 03 2006 | RNN | REXAHN PHARMACEUTI ... | Ahn Inok | Director | Option Exercise | D | 0.24 | 1,000,000 | 240,000 | 0 |